Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 1,093,803 | reported | 29 Dec 2025 | tx 114+5,136,400−2,638,908 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 14,000 | — | |
| 29 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 14,000 | 0.00 USD | deriv |
| 08 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 11,873 | — | |
| 08 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 11,873 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 8,267 | — | |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 158,454 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 47,826 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 8,267 | 0.00 USD | deriv |
| 26 Aug 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 115,000 | 2.24 USD | |
| 27 Aug 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 110,000 | 2.24 USD | |
| 26 Aug 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 115,000 | 20.28 USD | |
| 26 Aug 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 115,000 | 0.00 USD | deriv |
| 27 Aug 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 110,000 | 0.00 USD | deriv |
| 14 Feb 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 13,667 | — | |
| 14 Feb 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 13,667 | 0.00 USD | deriv |
| 27 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 14,000 | — | |
| 27 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 14,000 | 0.00 USD | deriv |
| 13 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 235,000 | 4.01 USD | |
| 13 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 235,000 | 0.00 USD | deriv |
| 10 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50,000 | 4.01 USD | |
| 10 Dec 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 50,000 | 21.93 USD | |
| 09 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 11,872 | — | |
| 09 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 11,872 | 0.00 USD | deriv |
| 10 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50,000 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 202,958 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 11 Jan 2016.